| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ITCH_0006700 | Exon-Exon | chr20:32996457-33069011 | chr20:34408651-34481206 | 2146 nt | 0.4278 |
| hsa_ITCH_0007400 | Exon-Exon | chr20:32996457-33095713 | chr20:34408651-34507908 | 142 nt | 0.4085 |
| hsa_ITCH_0007500 | Exon-Intron | chr20:32996519-32996790 | chr20:34408713-34408984 | 272 nt | 0.3309 |
| hsa_ITCH_0007600 | Intron-Exon-Intron | chr20:32997297-33003249 | chr20:34409491-34415443 | 250 nt | 0.3120 |
| hsa_ITCH_0008000 | Exon-Exon | chr20:33000321-33012331 | chr20:34412515-34424525 | 171 nt | 0.3801 |
| hsa_ITCH_0008100 | Exon-Exon | chr20:33000321-33037285 | chr20:34412515-34449480 | 125 nt | 0.3520 |
| hsa_ITCH_0008200 | Exon-Exon | chr20:33000321-33045279 | chr20:34412515-34457474 | 91 nt | 0.4396 |
| hsa_ITCH_0008300 | Exon-Exon | chr20:33000321-33050026 | chr20:34412515-34462221 | 125 nt | 0.3520 |
| hsa_ITCH_0008400 | Exon-Exon | chr20:33000321-33057925 | chr20:34412515-34470120 | 125 nt | 0.3520 |
| hsa_ITCH_0007900 | Exon-Exon | chr20:33000321-33059320 | chr20:34412515-34471515 | 1480 nt | 0.4486 |
A review consolidating research in humans and model organisms indicates that the circITCH functions as a tumor suppressor in glioma by sponging miR-214 to allow expression of ubiquitin-protein ligase E3, thereby suppressing proliferation and preventing apoptosis, while also targeting the Wnt/β-catenin pathway [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. In oesophageal squamous cell carcinoma, the circITCH is downregulated and increases ITCH expression to inhibit the Wnt/β-catenin pathway [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. circITCH hsa_circ_0001141 (circITCH) was found to be lower in the hearts of cancer patients suffering from doxorubicin-induced cardiomyopathy compared to those with dilated cardiomyopathy, hypertrophic cardiomyopathy, and healthy donors, and its expression ameliorates doxorubicin-induced cardiomyocyte injury [Tian et al. DOI:10.3390/molecules26041155].